<!DOCTYPE html>
<html >

<head>

  <meta charset="UTF-8">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <title>PhD thesis</title>
  <meta name="description" content="This is a PhD thesis written in real-time in Rstudio">
  <meta name="generator" content="bookdown 0.7 and GitBook 2.6.7">

  <meta property="og:title" content="PhD thesis" />
  <meta property="og:type" content="book" />
  
  
  <meta property="og:description" content="This is a PhD thesis written in real-time in Rstudio" />
  <meta name="github-repo" content="eliaseythorsson/phd_thesis" />

  <meta name="twitter:card" content="summary" />
  <meta name="twitter:title" content="PhD thesis" />
  
  <meta name="twitter:description" content="This is a PhD thesis written in real-time in Rstudio" />
  

<meta name="author" content="Elías Sæbjörn Eyþórsson">


<meta name="date" content="2018-11-22">

  <meta name="viewport" content="width=device-width, initial-scale=1">
  <meta name="apple-mobile-web-app-capable" content="yes">
  <meta name="apple-mobile-web-app-status-bar-style" content="black">
  
  
<link rel="prev" href="methods.html">
<link rel="next" href="discussion.html">
<script src="libs/jquery-2.2.3/jquery.min.js"></script>
<link href="libs/gitbook-2.6.7/css/style.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-bookdown.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-highlight.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-search.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-fontsettings.css" rel="stylesheet" />










<link rel="stylesheet" href="style.css" type="text/css" />
</head>

<body>



  <div class="book without-animation with-summary font-size-2 font-family-1" data-basepath=".">

    <div class="book-summary">
      <nav role="navigation">

<ul class="summary">
<li><a href="./">PhD Thesis Under Construction</a></li>

<li class="divider"></li>
<li class="chapter" data-level="1" data-path="index.html"><a href="index.html"><i class="fa fa-check"></i><b>1</b> Preamble</a></li>
<li class="chapter" data-level="2" data-path="intro.html"><a href="intro.html"><i class="fa fa-check"></i><b>2</b> Introduction</a><ul>
<li class="chapter" data-level="2.1" data-path="intro.html"><a href="intro.html#clinical-manifestations-of-streptococcus-pneumoniae"><i class="fa fa-check"></i><b>2.1</b> Clinical manifestations of <em>Streptococcus pneumoniae</em></a><ul>
<li class="chapter" data-level="2.1.1" data-path="intro.html"><a href="intro.html#acute-otitis-media"><i class="fa fa-check"></i><b>2.1.1</b> Acute otitis media</a></li>
<li class="chapter" data-level="2.1.2" data-path="intro.html"><a href="intro.html#pneumonia"><i class="fa fa-check"></i><b>2.1.2</b> Pneumonia</a></li>
<li class="chapter" data-level="2.1.3" data-path="intro.html"><a href="intro.html#invasive-pneumococcal-disease"><i class="fa fa-check"></i><b>2.1.3</b> Invasive pneumococcal disease</a></li>
</ul></li>
<li class="chapter" data-level="2.2" data-path="intro.html"><a href="intro.html#pneumococcal-vaccines"><i class="fa fa-check"></i><b>2.2</b> Pneumococcal vaccines</a><ul>
<li class="chapter" data-level="2.2.1" data-path="intro.html"><a href="intro.html#a-brief-history-of-pneumococcal-vaccination"><i class="fa fa-check"></i><b>2.2.1</b> A brief history of pneumococcal vaccination</a></li>
<li class="chapter" data-level="2.2.2" data-path="intro.html"><a href="intro.html#key-concepts-in-pneumococcal-vaccine-epidemiology"><i class="fa fa-check"></i><b>2.2.2</b> Key concepts in pneumococcal vaccine epidemiology</a></li>
<li class="chapter" data-level="2.2.3" data-path="intro.html"><a href="intro.html#the-impact-of-pneumococcal-conjugate-vaccines-on-otitis-media"><i class="fa fa-check"></i><b>2.2.3</b> The impact of pneumococcal conjugate vaccines on otitis media</a></li>
<li class="chapter" data-level="2.2.4" data-path="intro.html"><a href="intro.html#the-impact-of-pneumococcal-conjugate-vaccines-on-pneumonia"><i class="fa fa-check"></i><b>2.2.4</b> The impact of pneumococcal conjugate vaccines on pneumonia</a></li>
<li class="chapter" data-level="2.2.5" data-path="intro.html"><a href="intro.html#the-impact-of-pneumococcal-conjugate-vaccines-on-invasive-pneumococcal-disease"><i class="fa fa-check"></i><b>2.2.5</b> The impact of pneumococcal conjugate vaccines on Invasive pneumococcal disease</a></li>
</ul></li>
<li class="chapter" data-level="2.3" data-path="intro.html"><a href="intro.html#cost-effectiveness-in-the-context-of-pneumococcal-conjugate-vaccination"><i class="fa fa-check"></i><b>2.3</b> Cost-effectiveness in the context of pneumococcal conjugate vaccination</a><ul>
<li class="chapter" data-level="2.3.1" data-path="intro.html"><a href="intro.html#measurement-of-effectiveness-and-choice-of-health-outcomes"><i class="fa fa-check"></i><b>2.3.1</b> Measurement of effectiveness and choice of health outcomes</a></li>
<li class="chapter" data-level="2.3.2" data-path="intro.html"><a href="intro.html#estimating-resources-and-cost"><i class="fa fa-check"></i><b>2.3.2</b> Estimating resources and cost</a></li>
</ul></li>
</ul></li>
<li class="chapter" data-level="3" data-path="aims.html"><a href="aims.html"><i class="fa fa-check"></i><b>3</b> Aims</a></li>
<li class="chapter" data-level="4" data-path="methods.html"><a href="methods.html"><i class="fa fa-check"></i><b>4</b> Materials and methods</a><ul>
<li class="chapter" data-level="4.1" data-path="methods.html"><a href="methods.html#datasources"><i class="fa fa-check"></i><b>4.1</b> Data collection and sources</a><ul>
<li class="chapter" data-level="4.1.1" data-path="methods.html"><a href="methods.html#statisticsiceland"><i class="fa fa-check"></i><b>4.1.1</b> Statistics Iceland</a></li>
<li class="chapter" data-level="4.1.2" data-path="methods.html"><a href="methods.html#patientregistry"><i class="fa fa-check"></i><b>4.1.2</b> Landspitali University Hospital patient registry</a></li>
<li class="chapter" data-level="4.1.3" data-path="methods.html"><a href="methods.html#primarycareregistry"><i class="fa fa-check"></i><b>4.1.3</b> The Primary Care Registry</a></li>
<li class="chapter" data-level="4.1.4" data-path="methods.html"><a href="methods.html#vaccineregistry"><i class="fa fa-check"></i><b>4.1.4</b> The National Vaccine Registry</a></li>
<li class="chapter" data-level="4.1.5" data-path="methods.html"><a href="methods.html#prescriptionregistry"><i class="fa fa-check"></i><b>4.1.5</b> The National Drug Prescription Registry</a></li>
<li class="chapter" data-level="4.1.6" data-path="methods.html"><a href="methods.html#reimbursementdatabase"><i class="fa fa-check"></i><b>4.1.6</b> Reimbursement database of Icelandic Health Insurance</a></li>
</ul></li>
<li class="chapter" data-level="4.2" data-path="methods.html"><a href="methods.html#paper1"><i class="fa fa-check"></i><b>4.2</b> Impact on otitis media with treatment failure (Paper I)</a></li>
<li class="chapter" data-level="4.3" data-path="methods.html"><a href="methods.html#paper2"><i class="fa fa-check"></i><b>4.3</b> Impact on primary care visits for otitis media (Paper II)</a></li>
<li class="chapter" data-level="4.4" data-path="methods.html"><a href="methods.html#paper3"><i class="fa fa-check"></i><b>4.4</b> Impact on outpatient antimicrobial prescriptions (Paper III)</a></li>
<li class="chapter" data-level="4.5" data-path="methods.html"><a href="methods.html#paper4"><i class="fa fa-check"></i><b>4.5</b> Impact on tympanostomy tube procedures (Paper IV)</a></li>
<li class="chapter" data-level="4.6" data-path="methods.html"><a href="methods.html#paper5"><i class="fa fa-check"></i><b>4.6</b> Impact on respiratory associated hospitalizations (Paper V)</a></li>
<li class="chapter" data-level="4.7" data-path="methods.html"><a href="methods.html#paper6"><i class="fa fa-check"></i><b>4.7</b> Impact and cost-benefit analysis (Paper VI)</a></li>
</ul></li>
<li class="chapter" data-level="5" data-path="results.html"><a href="results.html"><i class="fa fa-check"></i><b>5</b> Results</a><ul>
<li class="chapter" data-level="5.0.1" data-path="results.html"><a href="results.html#statistics-iceland"><i class="fa fa-check"></i><b>5.0.1</b> Statistics Iceland</a></li>
<li class="chapter" data-level="5.0.2" data-path="results.html"><a href="results.html#landspitali-university-hospital-patient-registry"><i class="fa fa-check"></i><b>5.0.2</b> Landspitali University Hospital patient registry</a></li>
<li class="chapter" data-level="5.0.3" data-path="results.html"><a href="results.html#the-primary-care-registry"><i class="fa fa-check"></i><b>5.0.3</b> The Primary Care Registry</a></li>
<li class="chapter" data-level="5.0.4" data-path="results.html"><a href="results.html#the-national-vaccine-registry"><i class="fa fa-check"></i><b>5.0.4</b> The National Vaccine Registry</a></li>
<li class="chapter" data-level="5.0.5" data-path="results.html"><a href="results.html#the-national-drug-prescription-registry"><i class="fa fa-check"></i><b>5.0.5</b> The National Drug Prescription Registry</a></li>
<li class="chapter" data-level="5.0.6" data-path="results.html"><a href="results.html#reimbursement-database-of-icelandic-health-insurance"><i class="fa fa-check"></i><b>5.0.6</b> Reimbursement database of Icelandic Health Insurance</a></li>
<li class="chapter" data-level="5.1" data-path="results.html"><a href="results.html#paper-1"><i class="fa fa-check"></i><b>5.1</b> Paper 1</a></li>
</ul></li>
<li class="chapter" data-level="6" data-path="discussion.html"><a href="discussion.html"><i class="fa fa-check"></i><b>6</b> Discussion</a></li>
<li class="chapter" data-level="" data-path="references.html"><a href="references.html"><i class="fa fa-check"></i>References</a></li>
<li class="divider"></li>
<li><a href="https://github.com/rstudio/bookdown" target="blank">Published with bookdown</a></li>

</ul>

      </nav>
    </div>

    <div class="book-body">
      <div class="body-inner">
        <div class="book-header" role="navigation">
          <h1>
            <i class="fa fa-circle-o-notch fa-spin"></i><a href="./">PhD thesis</a>
          </h1>
        </div>

        <div class="page-wrapper" tabindex="-1" role="main">
          <div class="page-inner">

            <section class="normal" id="section-">
<div id="results" class="section level1">
<h1><span class="header-section-number">5</span> Results</h1>
<p>The results of papers I-VI are summarized in their respective subchapters. Because data was collected over a four year period from 2013-2017, and the papers that form this thesis were written and published at different times, the study period and population described in each paper varies slightly. They differ however only marginally from the final data summary described below.</p>
<p>When data from all registries are taken together, individual level information was available for 372,641 Icelandic citizens, of which 183,233 were female and 181,048 were male. Gender was unknown for 8,360 individuals. The full date of birth was known for 363,456 and the birth-year was available for the rest. The median birth-year for the whole study population was 1979 (IQR 1958-1997). Death was registered for 12,308 individuals during the study period.</p>
<div id="statistics-iceland" class="section level3">
<h3><span class="header-section-number">5.0.1</span> Statistics Iceland</h3>
<p>Statistics Iceland provided data on the immigration and emigration of all Icelandic children zero to four years of age from 2005-2017. Of the 57,695 Icelandic children born 2005 or later, 5,577 moved to or from the country 6,847 times. The proportion of children in each birth-cohort who moved at least once before five years of age, was consistently 9%-12% of those birth-cohorts who had full follow-up time (birth-cohorts 2005-2012).</p>
</div>
<div id="landspitali-university-hospital-patient-registry" class="section level3">
<h3><span class="header-section-number">5.0.2</span> Landspitali University Hospital patient registry</h3>
<p>All visits and hospitalizations with ICD-10 diagnostic codes compatible with respiratory infections (Table <a href="methods.html#tab:table-icd">4.1</a>) and procedural codes compatible with tympanostomy tube procedures (Table <a href="methods.html#tab:table-ncsp">4.2</a>), were extracted from Landspitali’s patient registry. The number of visits and hospitalizations with each of the study’s ICD-10 diagnoses recorded as the first diagnosis, are shown in Table <a href="results.html#tab:table-icd10-results">5.1</a>.</p>
<table>
<caption><span id="tab:table-icd10-results">Table 5.1: </span>Number of visits or hospitalizations with International Classification of Diseases, 10th revision codes used in the current study as the primary diagnosis</caption>
<thead>
<tr class="header">
<th align="left">ICD-10 code</th>
<th align="left">Disease</th>
<th align="right">Hospital visits</th>
<th align="right">Hospitalizations</th>
<th align="right">Primary care visits</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">A40</td>
<td align="left">Streptococcal sepsis</td>
<td align="right">37</td>
<td align="right">135</td>
<td align="right">68</td>
</tr>
<tr class="even">
<td align="left">A41</td>
<td align="left">Other sepsis</td>
<td align="right">370</td>
<td align="right">777</td>
<td align="right">279</td>
</tr>
<tr class="odd">
<td align="left">A48</td>
<td align="left">Other bacterial diseases, not elsewhere classified</td>
<td align="right">5</td>
<td align="right">28</td>
<td align="right">10</td>
</tr>
<tr class="even">
<td align="left">A49</td>
<td align="left">Bacterial infection of unspecified site</td>
<td align="right">123</td>
<td align="right">26</td>
<td align="right">1,861</td>
</tr>
<tr class="odd">
<td align="left">B00</td>
<td align="left">Herpesviral [herpes simplex] infections</td>
<td align="right">497</td>
<td align="right">22</td>
<td align="right">2,176</td>
</tr>
<tr class="even">
<td align="left">B08</td>
<td align="left">Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified</td>
<td align="right">76</td>
<td align="right">1</td>
<td align="right">655</td>
</tr>
<tr class="odd">
<td align="left">B33</td>
<td align="left">Other viral diseases, not elsewhere classified</td>
<td align="right">32</td>
<td align="right">4</td>
<td align="right">106</td>
</tr>
<tr class="even">
<td align="left">B34</td>
<td align="left">Viral infection of unspecified site</td>
<td align="right">25,601</td>
<td align="right">528</td>
<td align="right">329,179</td>
</tr>
<tr class="odd">
<td align="left">B95</td>
<td align="left">Streptococcus, Staphylococcus, and Enterococcus as the cause of diseases classified elsewhere</td>
<td align="right">12</td>
<td align="right">4</td>
<td align="right">40</td>
</tr>
<tr class="even">
<td align="left">B96</td>
<td align="left">Other bacterial agents as the cause of diseases classified elsewhere</td>
<td align="right">5</td>
<td align="right">7</td>
<td align="right">29</td>
</tr>
<tr class="odd">
<td align="left">G00</td>
<td align="left">Bacterial meningitis,not elsewhere classified</td>
<td align="right">79</td>
<td align="right">60</td>
<td align="right">3</td>
</tr>
<tr class="even">
<td align="left">H65</td>
<td align="left">Nonsuppurative otitis media</td>
<td align="right">2,803</td>
<td align="right">75</td>
<td align="right">38,585</td>
</tr>
<tr class="odd">
<td align="left">H66</td>
<td align="left">Suppurative and unspecified otitis media</td>
<td align="right">11,647</td>
<td align="right">244</td>
<td align="right">160,086</td>
</tr>
<tr class="even">
<td align="left">H70</td>
<td align="left">Mastoiditis and related conditions</td>
<td align="right">164</td>
<td align="right">86</td>
<td align="right">259</td>
</tr>
<tr class="odd">
<td align="left">H72</td>
<td align="left">Perforation of tympanic membrane</td>
<td align="right">1,270</td>
<td align="right">233</td>
<td align="right">1,947</td>
</tr>
<tr class="even">
<td align="left">H73</td>
<td align="left">Other disorders of tympanic membrane</td>
<td align="right">67</td>
<td align="right">3</td>
<td align="right">727</td>
</tr>
<tr class="odd">
<td align="left">J00</td>
<td align="left">Acute nasopharyngitis [common cold]</td>
<td align="right">3,525</td>
<td align="right">49</td>
<td align="right">124,984</td>
</tr>
<tr class="even">
<td align="left">J01</td>
<td align="left">Acute sinusitis</td>
<td align="right">4,625</td>
<td align="right">113</td>
<td align="right">152,076</td>
</tr>
<tr class="odd">
<td align="left">J02</td>
<td align="left">Acute pharyngitis</td>
<td align="right">1,869</td>
<td align="right">44</td>
<td align="right">124,874</td>
</tr>
<tr class="even">
<td align="left">J03</td>
<td align="left">Acute tonsillitis</td>
<td align="right">5,019</td>
<td align="right">213</td>
<td align="right">106,491</td>
</tr>
<tr class="odd">
<td align="left">J04</td>
<td align="left">Acute laryngitis and tracheitis</td>
<td align="right">983</td>
<td align="right">38</td>
<td align="right">19,288</td>
</tr>
<tr class="even">
<td align="left">J05</td>
<td align="left">Acute obstructive laryngitis [croup] and epiglottitis</td>
<td align="right">2,738</td>
<td align="right">40</td>
<td align="right">3,148</td>
</tr>
<tr class="odd">
<td align="left">J06</td>
<td align="left">Acute upper respiratory infections of multiple and unspecified sites</td>
<td align="right">3,649</td>
<td align="right">94</td>
<td align="right">110,236</td>
</tr>
<tr class="even">
<td align="left">J09</td>
<td align="left">Influenza due to certain identified influenza viruses</td>
<td align="right">250</td>
<td align="right">185</td>
<td align="right">9</td>
</tr>
<tr class="odd">
<td align="left">J10</td>
<td align="left">Influenza due to other identified influenza virus</td>
<td align="right">282</td>
<td align="right">151</td>
<td align="right">699</td>
</tr>
<tr class="even">
<td align="left">J11</td>
<td align="left">Influenza due to unidentified influenza virus</td>
<td align="right">1,003</td>
<td align="right">77</td>
<td align="right">34,949</td>
</tr>
<tr class="odd">
<td align="left">J12</td>
<td align="left">Viral pneumonia, not elsewhere classified</td>
<td align="right">206</td>
<td align="right">189</td>
<td align="right">189</td>
</tr>
<tr class="even">
<td align="left">J13</td>
<td align="left">Pneumonia due to Streptococcus pneumoniae</td>
<td align="right">129</td>
<td align="right">265</td>
<td align="right">80</td>
</tr>
<tr class="odd">
<td align="left">J14</td>
<td align="left">Pneumonia due to Hemophilus influenzae</td>
<td align="right">18</td>
<td align="right">44</td>
<td align="right">34</td>
</tr>
<tr class="even">
<td align="left">J15</td>
<td align="left">Bacterial pneumonia, not elsewhere classified</td>
<td align="right">2,489</td>
<td align="right">1,129</td>
<td align="right">1,870</td>
</tr>
<tr class="odd">
<td align="left">J16</td>
<td align="left">Pneumonia due to other infectious organisms, not elsewhere classified</td>
<td align="right">60</td>
<td align="right">37</td>
<td align="right">62</td>
</tr>
<tr class="even">
<td align="left">J17</td>
<td align="left">Pneumonia in diseases classified elsewhere</td>
<td align="right">17</td>
<td align="right">15</td>
<td align="right">38</td>
</tr>
<tr class="odd">
<td align="left">J18</td>
<td align="left">Pneumonia, unspecified organism</td>
<td align="right">8,576</td>
<td align="right">4,501</td>
<td align="right">66,232</td>
</tr>
<tr class="even">
<td align="left">J20</td>
<td align="left">Acute bronchitis</td>
<td align="right">2,431</td>
<td align="right">297</td>
<td align="right">148,963</td>
</tr>
<tr class="odd">
<td align="left">J21</td>
<td align="left">Acute bronchiolitis</td>
<td align="right">2,874</td>
<td align="right">707</td>
<td align="right">6,178</td>
</tr>
<tr class="even">
<td align="left">J22</td>
<td align="left">Unspecified acute lower respiratory infection</td>
<td align="right">356</td>
<td align="right">55</td>
<td align="right">9,425</td>
</tr>
<tr class="odd">
<td align="left">J32</td>
<td align="left">Chronic sinusitis</td>
<td align="right">3,298</td>
<td align="right">405</td>
<td align="right">52,899</td>
</tr>
<tr class="even">
<td align="left">J36</td>
<td align="left">Peritonsillar abscess</td>
<td align="right">1,095</td>
<td align="right">254</td>
<td align="right">1,239</td>
</tr>
<tr class="odd">
<td align="left">J40</td>
<td align="left">Bronchitis, not specified as acute or chronic</td>
<td align="right">893</td>
<td align="right">49</td>
<td align="right">77,272</td>
</tr>
<tr class="even">
<td align="left">J85</td>
<td align="left">Abscess of lung and mediastinum</td>
<td align="right">98</td>
<td align="right">41</td>
<td align="right">24</td>
</tr>
<tr class="odd">
<td align="left">J86</td>
<td align="left">Pyothorax</td>
<td align="right">20</td>
<td align="right">62</td>
<td align="right">48</td>
</tr>
<tr class="even">
<td align="left">J90</td>
<td align="left">Pleural effusion, not elsewhere classified</td>
<td align="right">560</td>
<td align="right">409</td>
<td align="right">599</td>
</tr>
<tr class="odd">
<td align="left">N30</td>
<td align="left">Cystitis</td>
<td align="right">6,112</td>
<td align="right">568</td>
<td align="right">133,560</td>
</tr>
<tr class="even">
<td align="left">N39</td>
<td align="left">Other disorders of urinary system</td>
<td align="right">12,901</td>
<td align="right">2,868</td>
<td align="right">36,154</td>
</tr>
<tr class="odd">
<td align="left">R05</td>
<td align="left">Cough</td>
<td align="right">2,471</td>
<td align="right">11</td>
<td align="right">83,948</td>
</tr>
<tr class="even">
<td align="left">R50</td>
<td align="left">Fever of other and unknown origin</td>
<td align="right">3,433</td>
<td align="right">557</td>
<td align="right">27,121</td>
</tr>
</tbody>
</table>
<p>A total of 169,585 records (of 74,740 individuals) were available, of which 135,841 (64,090) were visits to outpatient clinics or emergency departments and 33,744 (20,318) were hospital admissions. The most visits of a single individual was 170 and the most admissions, 31. The number of study procedures performed at Landspitali University Hospital is shown in Table <a href="results.html#tab:table-ncsp-results">5.2</a>.</p>
<table>
<caption><span id="tab:table-ncsp-results">Table 5.2: </span>Number of study NOMESCO Classification of Surgical Procedures performed in the current study</caption>
<thead>
<tr class="header">
<th align="left">NCSP code</th>
<th align="left">Description</th>
<th align="right">Number of procedures</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">EMSB00</td>
<td align="left">Excision of lesion of tonsil or adenoid</td>
<td align="right">1</td>
</tr>
<tr class="even">
<td align="left">EMSB10</td>
<td align="left">Tonsillectomy</td>
<td align="right">88</td>
</tr>
<tr class="odd">
<td align="left">EMSB15</td>
<td align="left">Intracapsular destruction of tonsils</td>
<td align="right">2</td>
</tr>
<tr class="even">
<td align="left">EMSB20</td>
<td align="left">Adenotonsillectomy</td>
<td align="right">101</td>
</tr>
<tr class="odd">
<td align="left">EMSB30</td>
<td align="left">Adenotomy</td>
<td align="right">170</td>
</tr>
<tr class="even">
<td align="left">EMSB99</td>
<td align="left">Other excision on tonsils and adenoids</td>
<td align="right">2</td>
</tr>
<tr class="odd">
<td align="left">EMSW99</td>
<td align="left">Other operation on tonsil or adenoids</td>
<td align="right">1</td>
</tr>
<tr class="even">
<td align="left">DCSA10</td>
<td align="left">Paracentesis of tympanic membrane</td>
<td align="right">289</td>
</tr>
<tr class="odd">
<td align="left">DCSA20</td>
<td align="left">Insertion of ventilating tube through tympanic membrane</td>
<td align="right">340</td>
</tr>
<tr class="even">
<td align="left">DCSW00</td>
<td align="left">Removal of ventilating tube from tympanic membrane</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>The age distribution of visits and hospital admissions are shown in Figure <a href="results.html#fig:density-age">5.1</a>. Though children and young adults comprise most of the visits due to study diagnoses, older adults make up the largest number of hospitalizations.</p>
<div class="figure"><span id="fig:density-age"></span>
<img src="_figures/results/2018-11-16-density-age.png" alt="Total number of contacts to Landspitali University Hospital and Primary Care Centers"  />
<p class="caption">
Figure 5.1: Total number of contacts to Landspitali University Hospital and Primary Care Centers
</p>
</div>
</div>
<div id="the-primary-care-registry" class="section level3">
<h3><span class="header-section-number">5.0.3</span> The Primary Care Registry</h3>
<p>The Primary Care Registry recorded all primary care health contacts for the period 2005-2015. All physician contacts associated with the diagnostic codes listed in Table <a href="methods.html#tab:table-icd">4.1</a> were extracted for the given period. A total of 1,963,439 separate contacts were recorded between 298,307 individual patients and 1,266 different physicians. The movst visits for a single individual was 212. The distribution in the number of contacts by age can be seen in Figure <a href="results.html#fig:density-age">5.1</a>.</p>
</div>
<div id="the-national-vaccine-registry" class="section level3">
<h3><span class="header-section-number">5.0.4</span> The National Vaccine Registry</h3>
<p>The National Vaccine Registry recorded all administered vaccine doses for the period 2005-2017. All recorded pneumococcal vaccine doses were extracted. A total of 110,712 doses of pneumococcal vaccines were administered to 51,601 individuals during the study period. The monthly number of administered doses per age-group and vaccine is shown in Figure <a href="results.html#fig:vaccine-time">5.2</a>.</p>
<div class="figure"><span id="fig:vaccine-time"></span>
<img src="_figures/results/2018-11-16-vaccine-time.png" alt="Monthly number of administered pneumococcal vaccine doses by type and age-group"  />
<p class="caption">
Figure 5.2: Monthly number of administered pneumococcal vaccine doses by type and age-group
</p>
</div>
<p>Table <a href="results.html#tab:vaccine-doses">5.3</a> shows the number of children in each birth-cohort who had received zero, one, two, and three doses of a pneumococcal conjugate vaccine by four years of age. Children who moved to or from the country before four years of age, were excluded from the table.</p>
<table>
<caption><span id="tab:vaccine-doses">Table 5.3: </span>The number of children in each birth-cohort who has received from zero to three pneumococcal conjugate vaccine doses</caption>
<thead>
<tr class="header">
<th align="left">Birth-cohort</th>
<th align="right">Zero doses</th>
<th align="right">One dose</th>
<th align="right">Two doses</th>
<th align="right">Three doses</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">2005</td>
<td align="right">4,207</td>
<td align="right">10</td>
<td align="right">5</td>
<td align="right">4</td>
</tr>
<tr class="even">
<td align="left">2006</td>
<td align="right">4,278</td>
<td align="right">26</td>
<td align="right">8</td>
<td align="right">3</td>
</tr>
<tr class="odd">
<td align="left">2007</td>
<td align="right">4,345</td>
<td align="right">51</td>
<td align="right">18</td>
<td align="right">13</td>
</tr>
<tr class="even">
<td align="left">2008</td>
<td align="right">4,348</td>
<td align="right">140</td>
<td align="right">62</td>
<td align="right">37</td>
</tr>
<tr class="odd">
<td align="left">2009</td>
<td align="right">4,292</td>
<td align="right">166</td>
<td align="right">237</td>
<td align="right">87</td>
</tr>
<tr class="even">
<td align="left">2010</td>
<td align="right">3,660</td>
<td align="right">158</td>
<td align="right">336</td>
<td align="right">549</td>
</tr>
<tr class="odd">
<td align="left">2011</td>
<td align="right">260</td>
<td align="right">44</td>
<td align="right">144</td>
<td align="right">3,976</td>
</tr>
<tr class="even">
<td align="left">2012</td>
<td align="right">197</td>
<td align="right">45</td>
<td align="right">154</td>
<td align="right">4,059</td>
</tr>
<tr class="odd">
<td align="left">2013</td>
<td align="right">165</td>
<td align="right">41</td>
<td align="right">123</td>
<td align="right">3,927</td>
</tr>
<tr class="even">
<td align="left">2014</td>
<td align="right">131</td>
<td align="right">49</td>
<td align="right">196</td>
<td align="right">3,956</td>
</tr>
<tr class="odd">
<td align="left">2015</td>
<td align="right">81</td>
<td align="right">40</td>
<td align="right">442</td>
<td align="right">3,404</td>
</tr>
</tbody>
</table>
<p>Some children in vaccine non-eligible cohorts received one, two or three doses of pneumococcal conjugate vaccines before four years of age. This generally occured at an older age than children in the vaccine eligible cohorts Figure <a href="results.html#fig:vaccine-age">5.3</a>.</p>
<div class="figure"><span id="fig:vaccine-age"></span>
<img src="_figures/results/2018-11-16-vaccine-age.png" alt="Age at the time of administered pneumococcal vaccine dose by birth date"  />
<p class="caption">
Figure 5.3: Age at the time of administered pneumococcal vaccine dose by birth date
</p>
</div>
</div>
<div id="the-national-drug-prescription-registry" class="section level3">
<h3><span class="header-section-number">5.0.5</span> The National Drug Prescription Registry</h3>
<p>The National Drug Prescription Registry (NDPR) recorded all filled prescriptions from 2005-2017. From this registry, all antibacterials for systemic use (J01), vaccines (J07), opthalmologicals (S01) and otologicals (S02) were extracted. A total of 4,020,624 prescriptions were recorded among 360,560 individuals. The number of prescriptions by therapeutic subgroup of the ATC classification system is shown in Table <a href="results.html#tab:table-atc-results">5.4</a>. The highest number of antimicrobial prescriptions filled by a single individual was 336 during the study period.</p>
<table>
<caption><span id="tab:table-atc-results">Table 5.4: </span>Number of prescriptions by Anatomical Therapeutic Chemical codes used in the current study</caption>
<thead>
<tr class="header">
<th align="left">ATC chemical subgroup code</th>
<th align="left">Description</th>
<th align="right">No of prescriptions</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">J01A</td>
<td align="left">Tetracyclines</td>
<td align="right">357,498</td>
</tr>
<tr class="even">
<td align="left">J01B</td>
<td align="left">Amphenicols</td>
<td align="right">0</td>
</tr>
<tr class="odd">
<td align="left">J01C</td>
<td align="left">Beta-lactam antibacterials, penicillins</td>
<td align="right">1,720,661</td>
</tr>
<tr class="even">
<td align="left">J01D</td>
<td align="left">Other beta-lactam antibacterials</td>
<td align="right">106,757</td>
</tr>
<tr class="odd">
<td align="left">J01E</td>
<td align="left">Sulfonamides and trimethoprim</td>
<td align="right">168,045</td>
</tr>
<tr class="even">
<td align="left">J01F</td>
<td align="left">Macrolides, lincosamides and streptogramins</td>
<td align="right">344,098</td>
</tr>
<tr class="odd">
<td align="left">J01G</td>
<td align="left">Aminoglycoside antibacterials</td>
<td align="right">71</td>
</tr>
<tr class="even">
<td align="left">J01M</td>
<td align="left">Quinolone antibacterials</td>
<td align="right">135,864</td>
</tr>
<tr class="odd">
<td align="left">J01R</td>
<td align="left">Combinations of antibacterials</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">J01X</td>
<td align="left">Other antibacterials</td>
<td align="right">96,318</td>
</tr>
<tr class="odd">
<td align="left">J07A</td>
<td align="left">Bacterial vaccines</td>
<td align="right">9,687</td>
</tr>
<tr class="even">
<td align="left">J07B</td>
<td align="left">Viral vaccines</td>
<td align="right">16,703</td>
</tr>
<tr class="odd">
<td align="left">J07C</td>
<td align="left">Bacterial and viral vaccines</td>
<td align="right">496</td>
</tr>
<tr class="even">
<td align="left">J07X</td>
<td align="left">Other vaccines</td>
<td align="right">0</td>
</tr>
<tr class="odd">
<td align="left">S01A</td>
<td align="left">Anti-infective opthalmologicals</td>
<td align="right">287,904</td>
</tr>
<tr class="even">
<td align="left">S02A</td>
<td align="left">Anti-infective otologicals</td>
<td align="right">1</td>
</tr>
<tr class="odd">
<td align="left">S01C</td>
<td align="left">Anti-inflammatory agents and anti-infectives opthalmologicals</td>
<td align="right">40,315</td>
</tr>
<tr class="even">
<td align="left">S02C</td>
<td align="left">Anti-inflammatory agents and anti-infectives otologicals</td>
<td align="right">25,218</td>
</tr>
</tbody>
</table>
<p>The distribution of antimicrobial prescriptions by age is shown in Figure <a href="results.html#fig:prescriptions-age">5.4</a>.</p>
<div class="figure"><span id="fig:prescriptions-age"></span>
<img src="_figures/results/2018-11-18-prescriptions-age.png" alt="Antimicrobial prescriptions by age"  />
<p class="caption">
Figure 5.4: Antimicrobial prescriptions by age
</p>
</div>
</div>
<div id="reimbursement-database-of-icelandic-health-insurance" class="section level3">
<h3><span class="header-section-number">5.0.6</span> Reimbursement database of Icelandic Health Insurance</h3>
<p>All interactions with independent health care practitioners were recorded in Icelandic Health Insurance’s reimbursement database. From this database, all records of otolaryngological procedures were extracted. A total of 51,814 procedures were recorded among 34,084 individuals.</p>

</div>
<div id="paper-1" class="section level2">
<h2><span class="header-section-number">5.1</span> Paper 1</h2>
<p>The total number of children under eighteen years of age who lived within Children’s Hospital Iceland’s referral region remained stable during the study period, decreasing from 62,067 in 2008 to 61,798 in 2015. The variation was more pronounced in the number of children under four years of age in the same region, which increased from 13,562 in 2008 to 14,644 in 2011, and then decreased to 13,272 in 2015.</p>
<p>During the period January 1, 2008 to December 31, 2015, 103,220 visits were recorded to the Children’s Hospital Iceland. The visits varied over the calendar year, spiking in the winter months and troughing in the summer months Figure <a href="results.html#fig:figure-monthly-visits">5.5</a>.</p>
<div class="figure"><span id="fig:figure-monthly-visits"></span>
<img src="_figures/paper_I/2018-11-03-monthly-visits.png" alt="Monthly number of visits to Children's Hospital Iceland"  />
<p class="caption">
Figure 5.5: Monthly number of visits to Children’s Hospital Iceland
</p>
</div>
<p>The total number of visits increased steadily during the study period, from 12,229 in 2008 to 14,502 in 2015. During the same period, 6,232 visits to the Children’s Hospital Iceland for acute otitis media were recorded for 4,624 individual children under four years of age, representing 4,994 distinct episodes. Of those episodes, 531 were treated with one or more doses of ceftriaxone.</p>
<p>47.5 per 1000 person- years in the prevaccine period to an incidence rate of 33.9 per 1000 person-years postvaccine. The effect of vaccine period varied sig- nificantly across age strata precluding Mantel–Haenzel adjustment. The crude overall IRR was 0.86 (95% CI: 0.81–0.91; P &lt; 0.001). A significant decrease in visits was observed only in children 2–3 years of age (IRR 0.71; 95% CI: 0.63–0.80; P &lt; 0.001. A nonsig- nificant trend toward a decrease was observed in other age strata. Children 0–1 and 3–4 years of age visited the Children’s Hospital because of episodes of AOM for a total of only 481 and 396 times, respectively,</p>
<p>Significantly fewer episodes of AOM were treated with ceftriaxone in the postvaccine period compared with those in the prevaccine period (Table 1). The effect was consistent across age strata with an overall Mantel–Haenzel adjusted IRR 0.45 (95% CI: 0.37–0.54; P &lt; 0.001). During the entire study period, only 16 epi- sodes of AOM in children 0–1 year of age, and 20 episodes in chil- dren 3–4 years of age, were treated with ceftriaxone. Age-specific incidence rates and incidence rate ratios are shown in Table 2. The relative risk of treatment with ceftriaxone if presenting to the Chil- dren’s Hospital with AOM decreased significantly after vaccination. The effect was consistent across age strata with a Mantel–Haenzel adjusted relative risk ratio of 0.53 (95% CI: 0.44–0.63; P &lt; 0.001. Episodes of pneumonia treated with ceftriaxone also decreased overall, from 251 treatment episodes in the prevaccine period to 90 in the postvaccine period, with a Mantel–Haenzel adjusted IRR 0.36 (95% CI: 0.28–0.45; P &lt; 0.001. This signifi- cant decrease was observed in all age strata. Ceftriaxone use for other indications in children &lt;4 years of age did not decrease sig- nificantly, with an IRR of 0.92 (95% CI: 0.84–1.02; P = 0.13. Age- specific incidence rates and incidence rate ratios by indication for each vaccine period are shown in Table 2. Quarterly incidence of ceftriaxone treatment episodes by indication is shown in Figure 1.</p>
<p>An overall decrease in incidence rate of ceftriaxone use in children &lt;18 years of age regardless of indication was noted at the Children’s Hospital Iceland after PHiD-CV10 introduction, from 0.93 treatment episodes per 1000 person-years in the prevaccine period to 0.80 in the postvaccine period with a crude overall IRR 0.86 (95% CI: 0.81–0.91; P &lt; 0.001). However, when analyzed by age group, this is exclusively because of a significant decrease in incidence rate of ceftriaxone use in children 0–3 years of age (IRR 0.73; 95% CI: 0.67–0.79; P &lt; 0.001). Ceftriaxone use did not decrease significantly in other age groups, and there was a trend toward increasing use in children 12–17 years of age (Figure 2).</p>

</div>
</div>
            </section>

          </div>
        </div>
      </div>
<a href="methods.html" class="navigation navigation-prev " aria-label="Previous page"><i class="fa fa-angle-left"></i></a>
<a href="discussion.html" class="navigation navigation-next " aria-label="Next page"><i class="fa fa-angle-right"></i></a>
    </div>
  </div>
<script src="libs/gitbook-2.6.7/js/app.min.js"></script>
<script src="libs/gitbook-2.6.7/js/lunr.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-search.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-sharing.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-fontsettings.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-bookdown.js"></script>
<script src="libs/gitbook-2.6.7/js/jquery.highlight.js"></script>
<script>
gitbook.require(["gitbook"], function(gitbook) {
gitbook.start({
"sharing": {
"github": false,
"facebook": true,
"twitter": true,
"google": false,
"linkedin": false,
"weibo": false,
"instapper": false,
"vk": false,
"all": ["facebook", "google", "twitter", "linkedin", "weibo", "instapaper"]
},
"fontsettings": {
"theme": "white",
"family": "sans",
"size": 2
},
"edit": {
"link": null,
"text": null
},
"download": ["phd_thesis.pdf", "phd_thesis.epub"],
"toc": {
"collapse": "subsection"
}
});
});
</script>

<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    var src = "";
    if (src === "" || src === "true") src = "https://cdn.bootcss.com/mathjax/2.7.1/MathJax.js?config=TeX-MML-AM_CHTML";
    if (location.protocol !== "file:" && /^https?:/.test(src))
      src = src.replace(/^https?:/, '');
    script.src = src;
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>
</body>

</html>
